Informations sur le produit
- 1-[(6-Chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-1H-indole-3-ethanamine
- 2-[1-(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonylindol-3-yl]ethanamine
- 2-[1-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]-1H-indol-3-yl]ethylamine
- 1H-Indole-3-ethanamine, 1-[(6-chloroimidazo[2,1-b]thiazol-5-yl)sulfonyl]-
WAY 181187 is a specific agonist of the 5-HT6 receptor. It has been shown to inhibit the signal pathways and locomotor activity in rats, and has cancer-inhibiting effects. WAY 181187 has also been shown to be an inhibitor of 5-HT6 receptors, which are involved in the transmission of serotonin signals. 5-HT6 receptors are located primarily on neurons in the brain that control locomotion, mood, anxiety and appetite. They have also been implicated as a potential target for treatment of depression and anxiety disorders. WAY 181187 is structurally similar to a serotonin molecule with an oxygen atom replaced by sulfur (5-ht). The tautomeric form of this molecule is a 5-ht agonist. This drug inhibits glutamate from binding to its receptors on neuronal cells and appears to have electrophysiological properties that are different from other drugs used for the treatment of Parkinson's disease.
Propriétés chimiques
Question d’ordre technique sur : 3D-EXA40349 WAY 181187
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages